EWA
TEVA icon

EP Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

EP Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
9,464
+2,078
+28% +$69.2K ﹤0.01% 1253
2026
Q1 		$222K Sell
7,386
-1,681
-19% -$54.1K ﹤0.01% 1348
2025
Q4 		$283K Buy
+9,067
New +$223K ﹤0.01% 1172
2025
Q2 		– Sell
-22,806
Closed -$351K – 1473
2025
Q1 		$351K Sell
22,806
-1,146
-5% -$20.5K ﹤0.01% 840
2024
Q4 		$528K Sell
23,952
-1,190
-5% -$21.6K ﹤0.01% 676
2024
Q3 		$453K Buy
+25,142
New +$440K ﹤0.01% 721

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

EP Wealth Advisors's TEVA Position: Q2 2026 in Review

EP Wealth Advisors increased its Teva Pharmaceuticals (TEVA) stake by 28% in Q2 2026, buying an estimated $69.2K and bringing the position to 9,464 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

EP Wealth Advisors first reported a position in TEVA in Q3 2024 and has held it in 6 quarters since. The position peaked at $528K in Q4 2024. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • EP Wealth Advisors held 9,464 shares of Teva Pharmaceuticals worth $321K as of Q2 2026.
  • EP Wealth Advisors bought 2,078 Teva Pharmaceuticals shares in Q2 2026, an estimated $69.2K.
  • Teva Pharmaceuticals made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #1253 holding.
  • EP Wealth Advisors first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • EP Wealth Advisors's Teva Pharmaceuticals position peaked at $528K in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.